Scohia Pharma is a biotech startup dedicated to advancing patient care with swift, innovative solutions in renal and metabolic therapies. Founded in 2017, the company combines substantial research and development resources with agility in decision-making. With a focus on enhancing patient quality of life, Scohia Pharma aims to deliver innovative therapeutic medications for renal and metabolic conditions to patients and healthcare professionals. The company's last investment round totaled ¥10.00B in a corporate round investment on 14 March 2017, with participation from INCJ, Medipal Holdings, and Takeda.
SCOHIA PHARMA
Dedicated to advancing patient care with swift, innovative solutions in renal and metabolic therapies.
Founded 2017
1 employees
Corporate Round
Total: $10.00B
Biotechnology, Health Care
General Information
Company Name
SCOHIA PHARMA
Founded Year
2017
Employees
1
Industries
Biotechnology, Health Care
Funding Stage
Corporate Round
BounceWatch is an independent company data service, not affiliated with SCOHIA PHARMA. To contact SCOHIA PHARMA, visit scohia.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About SCOHIA PHARMA
Taxonomy: biotech, renal therapies, metabolic therapies, innovation, pharmaceuticals, quality of life, medication, agility, decision-making
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Corporate Round | ¥10.00B | 3 |
|
14 Mar 2017 |
SCOHIA PHARMA Alternatives & Competitors
View All Alternatives
SCOHIA PHARMA vs
Pioneering novel therapies to address cancer and metabolic disorders by targeting essential cellular...
Debt Financing
Biotechnology, Health Care
SCOHIA PHARMA vs
Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrotic conditi...
Series C
Biopharma, Biotechnology
SCOHIA PHARMA vs
Developing life-enhancing therapeutic products for diabetes and obesity with proprietary peptide che...
Series A
Biotechnology, Health Care
FAQ About SCOHIA PHARMA
Dedicated to advancing patient care with swift, innovative solutions in renal and metabolic therapies.
SCOHIA PHARMA was founded in 2017.
SCOHIA PHARMA operates in Biotechnology and Health Care. Its work centres on biotech, renal therapies, metabolic therapies and innovation.
SCOHIA PHARMA has approximately 1 employees.
SCOHIA PHARMA has completed 1 funding round, raising a total of $10.00B. The latest funding stage is Corporate Round.
Top alternatives and competitors to SCOHIA PHARMA include Petra Pharma, Inversago Pharma, Marcadia Biotech, Courtagen Life Sciences, VectivBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SCOHIA PHARMA and Petra Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for SCOHIA PHARMA, https://bouncewatch.com/company/scohia-pharma, updated 15 January 2025. When citing, please name BounceWatch and link this page.
